Emmaus Life Sciences, Inc. (EMMA) Financials
EMMA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 18.7 million | 86.6 million |
| Dec. 31, 2025 | 21.4 million | 85.0 million |
| Sept. 30, 2025 | 20.8 million | 80.2 million |
| June 30, 2025 | 23.3 million | 79.0 million |
EMMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -344000 | 1000 |
| Dec. 31, 2025 | 2.2 million | 7000 |
| Sept. 30, 2025 | 409000 | 9000 |
| June 30, 2025 | -2.9 million | -1000 |
EMMA Net Income
No data available :(
EMMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 1.1 million | 2.3 million | 1.3 million |
| Dec. 31, 2025 | 2.1 million | 2.3 million | 1.8 million |
| Sept. 30, 2025 | 293000 | 2.3 million | 1.8 million |
| June 30, 2025 | 886000 | 2.3 million | 1.9 million |
EMMA Shares Outstanding
EMMA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 40000 | 2.6 million | 747000 |
| Dec. 31, 2025 | - | 31000 | 2.7 million | 898000 |
| Sept. 30, 2025 | - | 50000 | 2.4 million | 655000 |
| June 30, 2025 | 1000 | 56000 | 3.0 million | 674000 |
EMMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 2.0 million | 168000 |
| Dec. 31, 2025 | 3.9 million | 235000 |
| Sept. 30, 2025 | 3.4 million | 247000 |
| June 30, 2025 | 2.8 million | 150000 |
EMMA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
EMMA
Price: $0.01
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -0.12
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30500
Market Capitalization: 617657